Vironova BioAnalytics
Offers a range of products and services which can be used in development of particles for vaccines, drug delivery and gene therapy as well as viral safety testing and material quality control.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 24 % | 70 % | (14 %) | 54 % | 13 % | 12 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (112 %) | (58 %) | (119 %) | (73 %) | (154 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (134 %) | (83 %) | (164 %) | (113 %) | (187 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Vironova AB is a biotechnology company specializing in the analysis of nanoparticles using Transmission Electron Microscopy (TEM). The company offers a comprehensive suite of hardware, software, and services designed to provide detailed and accurate nanoparticle analysis. Vironova serves clients in the pharmaceutical and biotechnology industries, helping them to ensure the quality and efficacy of their nanoparticle-based products. Operating in the high-tech biotechnology market, Vironova's business model revolves around selling specialized TEM equipment, proprietary software, and offering expert analytical services. The company generates revenue through the sale of its products, as well as through service contracts and consulting fees.
Keywords: TEM, nanoparticles, biotechnology, pharmaceutical, software, hardware, analysis, quality control, consulting, high-tech.